Labgenomics Co Ltd
KOSDAQ:084650
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 150
5 100
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Labgenomics Co Ltd
Accrued Liabilities
Labgenomics Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Labgenomics Co Ltd
KOSDAQ:084650
|
Accrued Liabilities
₩4.5B
|
CAGR 3-Years
71%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Accrued Liabilities
₩205.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Accrued Liabilities
₩19.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Accrued Liabilities
₩2.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Accrued Liabilities
₩1.4B
|
CAGR 3-Years
28%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Accrued Liabilities
₩466.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Labgenomics Co Ltd
Glance View
LabGenomics Co., Ltd. engages in the provision of vitro diagnostic products and services. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2013-07-01. The firm mainly provides IVD services, including general diagnostic check services, molecular diagnostic check services, and research and development services. The Company’s IVD products include deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) kits and others. The company also provides examination for breast cancer and colorectal cancer, biosensor for point of care testing (POCT) and others. The company also provides healthy food.
See Also
What is Labgenomics Co Ltd's Accrued Liabilities?
Accrued Liabilities
4.5B
KRW
Based on the financial report for Jun 30, 2024, Labgenomics Co Ltd's Accrued Liabilities amounts to 4.5B KRW.
What is Labgenomics Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
45%
Over the last year, the Accrued Liabilities growth was 189%. The average annual Accrued Liabilities growth rates for Labgenomics Co Ltd have been 71% over the past three years , 45% over the past five years .
You don't have any saved screeners yet
